40P Can we predict which TIL products will react against NSCLC tumours based on the immune infiltrates?. (December 2022) - Castenmiller, S.; Kanagasabesan, N.; de Groot, R.; Guislain, A.; van Loenen, M.; Monkhorst, K.; Hartemink, K.; Klomp, H.M.; Smit, E.; Haanen, J.B.A.G.; Wolkers, M.